Cadrenal Therapeutics CVKD
NASDAQ CVKD
$0.95 -0.02 (-2.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cadrenal Therapeutics (CVKD) Cash from Investing Activities (2022 - 2025)

Updated

Cadrenal Therapeutics' Cash from Investing Activities came in at -$5,104 for FY2025, compared with -$6,537 in FY2024.

Analysis

Cadrenal Therapeutics (CVKD) Cash from Investing Activities (2022 - 2025) Analysis & Trends

Going back to FY2022, Cadrenal Therapeutics' Cash from Investing Activities data covers 4 years.

  • The five-year range for annual Cash from Investing Activities is -$6,537 (FY2024) to -$2,279 (FY2022).
  • Per Business Quant, earlier years put Cash from Investing Activities at -$6,537 in FY2024, -$3,254 in FY2023 and -$2,279 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Cadrenal Therapeutics 2.94 Mn -9.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -1,853.00
Mar 31, 2025 -3,251.00
Sep 30, 2023 -1.00
Dec 31, 2022 -1.00
API Access

Cadrenal Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=CVKD&period=max&api_key=YOUR_API_KEY